Pharmacy Updates:

 

1/2022 – Metformin 750 mg ER tab by Viona Pharmaceuticals English / Spanish

12/2021 – 2022 Opioid Management Program: Member Notification English / Spanish

08/2021 – Frequently Asked Influenza (Flu) Questions: 2021-2022 Season English / Spanish

01/2021 – 2021 Opioid Drug Management Program: Member Notification English / Spanish

12/2020 – Warning on the concurrent use of Opioids and Benzodiazepines  English / Spanish

12/2020 – 2021 Formulary Updates English / Spanish

08/2020 – Frequently Asked Influenza (Flu) Questions: 2020-2021 Season English /Spanish

01/2020 – Safer Use of Opioid Pain Medications English / Spanish

11/2019 – 2020 Opioid Drug Management Program: Member Notification English / Spanish

 

Drug news and safety alerts:

 

12/2021 – Enoxaparin Sodium 40mg/0.4 mL injection by Sandoz English / Spanish

11/2021 – Lupin Pharmaceuticals’ Irbesartan and Irbesartan-HCTZ tablets English / Spanish

11/2021 – Drug Recall Notice for one lot of GLUCAGON® Emergency Kit English / Spanish

10/2021 – Drug Recall Notice Chantix tablets – All lots English / Spanish

09/2021 – FDA Drug Safety Communication: Xeljanz/Xeljanz XR (tofacitinib), Olumiant (baricitinib) and Rinvoq (upadacitinib) English / Spanish

08/2021 – Drug Recall Notice Chantix tablets English / Spanish

07/2021 – Drug Recall Notice Metformin HCl Extended-Release Tablets, USP 750 mg English / Spanish

05/2021 – Drug Recall Notice NP Thyroid tablets English / Spanish

02/2021 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR English / Spanish

02/2021 – Drug Recall Notice Enoxaparin Sodium, USP by Apotex English / Spanish

07/2020 – Drug Recall Notice Lupin Pharmaceuticals Metformin Hydrochloride ER 500 mg and 1000mg tablets English / Spanish

07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets English / Spanish

06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets English / Spanish

06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets English / Spanish

05/2020 – Drug Recall Notice NP Thyroid tablets English / Spanish

04/2020 – Drug Recall Notice- Tetracycline 250mg and 500mg capsules English / Spanish

04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products English / Spanish

01/2020 – Drug Recall Notice Ranitidine capsules (Appco) English / Spanish

01/2020 – Drug Recall Notice Mirtazapine 7.5 mg tablets lot #03119002A3 (Aurobindo) English / Spanish

11/2019 – Drug Recall Notice Ranitidine tablets and syrup (Amneal) English / Spanish

11/2019 – Drug Recall Notice Ranitidine capsules, tablets and syrup (Aurobindo) English / Spanish

11/2019 – Drug Recall Notice Ranitidine capsules and syrup (Lannett and Novitium) English / Spanish

10/2019 – Drug Recall Notice Mylan’s Alprazolam products English / Spanish

10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine Products English / Spanish

10/2019 – Drug Recall Notice Sandoz Ranitidine Capsules English / Spanish

10/2019 – FDA Drug Safety Communication: Zantac (Ranitidine) English / Spanish

09/2019 – Drug Recall Notice -Natpara (Parathryoid Hormone for Injection)  English / Spanish 

09/2019 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR English / Spanish

08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS  English / Spanish

08/2019 – Drug Recall Notice Replax 40 mg tablets  English / Spanish

08/2019 – Drug Recall Notice Altair Pharmaceuticals- Ophthalmics English / Spanish

05/2019 – Drug Recall Notice Losartan and Losartan HCTZ English / Spanish

05/2019 – Drug Recall Losartan English / Spanish

04/2019 – Drug Recall Notice – Losartan Legacy MFXR English / Spanish

04/2019 – Drug Recall Notice – Valsartan – English / Spanish

04/2019 – Drug Recall Notice Losartan and Losartan HCTZ English / Spanish

04/2019 – Drug Recall Notice Losartan English / Spanish

04/2019 – Drug Recall Notice Losartan HCTZ  English / Spanish

01/2019 – Drug recall notice Irbesartan and Irbesartan HCTZ  English / Spanish

01/2019 – Drug recall notice for losartan and losartan-containing drug products English / Spanish

 

 

H4140_RXINFO_C
Last Updated: 01/10/2022